The World Boxing Council has cleared boxer Conor Bean of all liability for a positive test for clomiphene that caused the suspension of his scheduled October 2022 bout against Chris Eubanks Jr. For the opposite sample collected from the controls conducted in between July and September
The positive test revealed clomiphene, a fertility enhancer for women that increases testosterone levels in men. Ben has always maintained that he has never ingested banned substances intentionally or intentionally. His team provided a detailed report of his diet in the days before the controls in early February to say it may be behind the opposite result.
Read also:
The WBC consulted a nutritionist who endorsed the theory that Conor Bean’s higher egg consumption during the observation period was a reasonable explanation. Thus, the WBC said in a statement “there was no conclusive evidence that Connor Penn intentionally or knowingly took clomiphene.”
The WBC returned the British boxer to the world rankings. “Mr. Benn’s position in the WBC rankings will depend solely on his merits and the usual factors which the WBC ranking committee applies to eligible boxers.”
Despite this decision, Connor Bean’s case is still under investigation by the UK Anti-Doping Agency and the British Boxing Control Board. Until this process is complete, Benn Boxing will not be licensed in the UK, but could be based in another country. Penn’s last fight was in April 2022, when he defeated Chris Van Heerden by knockout in his WBA welterweight title defense.
The World Boxing Council also announced that it would report the case to the World Anti-Doping Agency (WADA) due to its concern about “false positives from eating contaminated food”.
“Food fanatic. Organizer. Hipster-friendly tv specialist. Avid reader. Devoted web ninja.”